Brief: Castle Biosciences Presents New Data From Collaboration With The National Cancer Institute’S (Nci) Surveillance, Epidemiology And End Results (Seer) Program
27/10/2022 12:52
Oct 27 (Reuters) - Castle Biosciences Inc CSTL.O :
* CASTLE BIOSCIENCES PRESENTS NEW DATA FROM COLLABORATION
WITH THE
NATIONAL CANCER INSTITUTE’S (NCI) SURVEILLANCE, EPIDEMIOLOGY AND
END RESULTS (SEER) PROGRAM
Source text for Eikon: ID:nBw2QLqMJa
Further company coverage: CSTL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million